← 產業報告目錄
Long Acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered, Material Used And End-User, Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-21頁數 180報告編號 INSIGHTACE-90dd292382
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Long Acting Drug Delivery Technologies Services Market stood at USD 13.7 Bn in 2023, and is projected to reach USD 30.2 Bn by 2031, recording a CAGR of 10.6% from 2024 through 2031.
Long Acting Drug Delivery Technologies Services covers The global long-acting drug delivery technologies and services market is witnessing robust growth due to the demand for improved patient adherence and therapeutic outcomes. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Long-Acting Drug Delivery Technologies and Services Market Snapshot
Chapter 4. Global Long-Acting Drug Delivery Technologies and Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technique Estimates & Trend Analysis
5.1. by Technique & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technique:
5.2.1. Long-Acting Injectables
5.2.2. Long-Acting Hydrogels
5.2.3. Long-Acting Implants
5.2.4. LongActing Microneedles
5.2.5. Nanocrystal Suspensions
Chapter 6. Market Segmentation 2: By Type of Molecule Delivered Estimates & Trend Analysis
6.1. By Type of Molecule Delivered & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Molecule Delivered:
6.2.1. Small Molecules
6.2.2. Biologics
6.2.3. Other Molecules (Peptides)
Chapter 7. Market Segmentation 3: by Material-Used Estimates & Trend Analysis
7.1. by Material-Used & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Material-Used:
7.2.1. Polymer-based
7.2.2. Non-polymer based
Chapter 8. Market Segmentation 4: By Dosage Forms Estimates & Trend Analysis
8.1. By Dosage Forms & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Dosage Forms:
8.2.1. Long-acting Injectables
8.2.2. Long-acting Implantable
8.2.3. Topical / Transdermal
8.2.4. Vaginal
8.2.5. Other Dosage Forms
Chapter 9. Market Segmentation 5: By Distribution Channels Estimates & Trend Analysis
9.1. By Distribution Channels & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:
9.2.1. Hospitals and Retail Pharmacies
9.2.2. Research and Academics
9.2.3. Others
Chapter 10. Long-Acting Drug Delivery Technologies and Services Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.1.2. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.1.3. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.1.4. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.1.5. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.1.6. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.2. Europe
10.2.1. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.2.2. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.2.3. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.2.4. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.2.5. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.2.6. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.3.2. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.3.3. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.3.4. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.3.5. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.3.6. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.4. Latin America
10.4.1. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.4.2. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.4.3. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.4.4. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.4.5. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.4.6. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.5.2. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.5.3. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.5.4. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.5.5. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and By Distribution Channels, 2023-2031
10.5.6. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Adare Pharma Solutions
11.2.2. Alkermes
11.2.3. AMW Gmb
11.2.4. Camurus AB
11.2.5. Corium, LLC.
11.2.6. Creative Biolabs
11.2.7. Delpor, Inc.
11.2.8. Durect Corporation
11.2.9. Hanmi Pharm Co Ltd.
11.2.10. Heron Therapeutics, Inc.
11.2.11. Integral BioSystems
11.2.12. NANEXA AB
11.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們